The p53 tumor suppressor gene in anticancer agent-induced apoptosis and chemosensitivity of human gastrointestinal cancer cell lines

Cancer Chemotherapy and Pharmacology

Volumn 43, Issue 1, 1999, Pages 43-49

  Yamamoto, Manabu ^a,c   Maehara, Yoshihiko ^b   Oda, Shinya ^a   Ichiyoshi, Yuji ^b   Kusumoto, Tetsuya ^a   Sugimachi, Keizo ^a,b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Apoptosis; Cell cycle; Chemosensitivity; Gastrointestinal cancer

Indexed keywords

ANTINEOPLASTIC AGENT; DNA; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; PROTEIN P53;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL KILLING; CHEMOSENSITIVITY; CONTROLLED STUDY; DELETION MUTANT; DIGESTIVE SYSTEM CANCER; DNA DAMAGE; DRUG TARGETING; GENE SEQUENCE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; DNA DAMAGE; DNA, NEOPLASM; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GASTROINTESTINAL NEOPLASMS; GENES, P53; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TUMOR CELLS, CULTURED;

EID: 0032913620     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050861     Document Type: Article

References (40)

1. 1. Kizaki H, Ohnishi Y, Azuma Y, Mizuno Y, Ohsaka F (1992) Arabinosylcytosine and 5′ azacytidine induce internucleosomal DNA fragmention and cell death in thymocytes. Immunopharmacology 24: 219
2. 2. Askew DS, Ashmun RA, Simmons BC, Cleveland JL (1991) Constitutive c-myc expression in an IL-3 dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6: 1915
3. 3. Columbel M, Olsson CA, Ng PY, Buttyan R (1992) Hormone regulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle. Cancer Res 52: 4313
4. 4. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DL (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119
5. 5. Shi Y, Glynn JM, Guilbert LJ, Cotter TG, Bissonnette RP, Green DR (1992) Role of c-myc in activation induced apoptosis in T cell hybridoma. Science 257: 212
6. 6. Ryan JJ, Danish R, Gottlieb CA, Clarke MF (1993) Cell cycle analysis of p53 induced cell death in murine erythroleukemia cells. Mol Cell Biol 13: 711
7. 7. Arends MJ, Wyllie AH (1991) Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol 32: 223
8. 8. Cohen JJ, Duke RC (1992) Apoptosis and programmed cell death in immunity. Annu Rev Immunol 10: 267
9. 9. Cohen JJ (1993) Overview: mechanism of apoptosis. Immunol Today 14: 126
10. 10. Peitch MC, Plazar B, Stephan H, Crompton T, McDonald HR, Mannaherz HG, Tschop J (1993) Characterization of the endogenous deoxyribonuclease involved in apoptosis. EMBO J 12: 371
11. 11. Thibodeau SN, Bren G, Schaid D (1993) Microsatellite instability in cancer of the proximal colon. Science 260: 816
12. 12. Harvery M, Sands AT, Weiss RS, Hegi ME, Wiseman RW, Pantazis P, Giovanella BC, Tainsky MA, Bradley A, Donehower LA (1993) In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 8: 2457
13. 13. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB (1992) Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 89: 7491
14. 14. Lowe SW, Ruley HE, Jacks T, Housman DE (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957
15. 15. Bakalkin G, Yokovleva T, Selivanova G, Magnusson KP, Szekely L, Kiselva E, Klein G, Terenius L, Wiman KG (1994) p53 binds single-stranded DNA ends and catalyzes DNA renaluration and strand transfer. Proc Natl Acad Sci USA 91:413
16. 16. Yin Y, Taninsky MA, Bischoff FZ, Strong LC, Wahl GM (1992) Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70: 937
17. 17. Hull PA, McKee PH, Menage HP, Dover R, Lane DP (1993) High level of p53 protein in UV-irrudiated normal human skin. Oncogene 8: 203
18. 18. Eliyahu D, Goldfinger N, Pinhasi-Kimhi O, Shaulsky G, Skurnik Y, Arai N, Rotter V, Oren M (1988) Meth A fibrosarcoma cells express two transforming mutant p53 species. Oncogene 3: 313
19. 19. Lee JM, Bernstein A (1993) p53 mutations increase resistance to ionizing radiation. Proc Natl Acad Sci USA 90: 5742
20. 20. Wagner AJ, Small MB, Hay N (1993) Myc-mediated apoptosis is blocked by ectopic expression of bcl-2. Mol Cell Biol 260: 2432
21. 21. Fan S, El-Deiry WS, Bae I, Freeman J, Jondle D, Bhatia K Fornace AJ Jr, Magrath I, Kohn KW, O'Connor PM (1994) p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damage agents. Cancer Res 54: 5824
22. 22. Biard DSF, Martin M, Le Rhun Y, Duthtu A, Lefaix JL, May E, May P (1994) Concomitant p53 gene mutation and increased radiosensitivity in rat lung embryo epithelial cells during neoplastic development. Cancer Res 54: 3361
23. 23. Matsuoka H, Sugimachi K, Ueo H, Kuwano H, Nakano S, Nakayama M (1987) Sex hormone response of a newly established squamous cell line derived from clinical esophageal carcinoma. Cancer Res 47: 4134
24. 24. Micetich K, Zwelling LA, Kohn KW (1983) Quenching of DNA: platinum (II) monoadducts as a possible mechanism of resistance to cis-diamminedichloroplatinum (II) in L1210 cells. Cancer Res 43: 3609
25. 25. Chomczynski P, Sacchi N.(1987) Single step method of RNA isolated by acid-guanidinium-thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156
26. 26. Phillips RM, Sarang M, Gibson NW (1993) Semi-quantitative measurement of gene expression by RT-PCR: a cautionary tale. Int J Oncol 3: 1097
27. 27. Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, Gazder AF, Willman CL, Griffith B, Von Hoff DD, Roninson IB (1990) Quantitative analysis of MDRI (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 87: 7160
28. 28. Kolodner RD, Hall NR, Lipford J, Kane MF, Morrison PT, Finan PJ, Burn J, Chapman P, Earabino C, Merchant E, Bishop DT (1995) Structure of the human MLHI locus and analysis of a large hereditary nonpolyposis colorectal carcinoma kindred for mlhl mutations. Cancer Res 55: 242
29. 29. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M (1991) Wild type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature 352: 345
30. 30. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 352: 849
31. 31. Lowe SW, Schmitt EM, Smith SW, Osborne B, Jacks T (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847
32. 32. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace AJ Jr (1992) A mammalian cell cycle check point pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71: 587
33. 33. O'Conner PM, Jackman J, Jondle D, Bhatia K, Magrath I, Kohn KW (1993) Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Res 53: 4776
34. 34. McIlwrath AJ, Vasey PA, Ross GM, Brown R (1994) Cell cycle arrest and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity. Cancer Res 54: 3718
35. 35. Li CY, Nagasawa H, Dahlberg WK, Little JB (1995) Diminished capacity for p53 in mediating a radiation-induced G1 arrest in established human tumor cell line. Oncogene 11: 1885
36. 36. Curtin NJ, Harris AL, Aherne GW (1991) Mechanism of cell death following thymidylate synthase inhibition: 2′-deoxyuridine-5′-triphosphate accumulation, DNA damage, and growth inhibition following exposure to CB3717 and dipyridumole. Cancer Res. 51: 2346
37. 37. Pritchard DM, Watson AJM, Potten CS, Jackman AL, Hickman JA (1997) Inhibition by uridine but not thymidine of p53-dependenl intestinal apoplosis iniliated by 5-fluorouracil: evidence for the involvement of RNA perturbation. Proc Natl Acad Sci USA 94: 1795
38. 38. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253: 49
39. 39. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, Jacks T (1994) p53 status and the efficacy of cancer therapy in vivo. Science 266: 807
40. 40. Fisher DE (1994) Apoptosis in cancer therapy: crossing the threshold. Cell 78: 539